4-aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis

Journal of Neuroimmune Pharmacology

Volumn 4, Issue 3, 2009, Pages 317-327

  Keblesh, James P ^a,b   Dou, Huanyu ^a,b   Gendelman, Howard E ^a,b   Xiong, Huangui ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

4 aminopyridine; EPSP; Hippocampal slice; HIV 1 encephalitis; Learning and memory; Voltage gated K+ channels

Indexed keywords

4 AMINOPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ESCAPE BEHAVIOR; EXPERIMENTAL MODEL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEARNING; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; SYNAPSE; VIRUS ENCEPHALITIS;

4-AMINOPYRIDINE; AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN; CELL SEPARATION; HIPPOCAMPUS; HIV-1; LEARNING; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MEMORY; MICE; MICE, SCID; MICROSCOPY, ELECTRON; MONOCYTES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; SPACE PERCEPTION; SWIMMING; SYNAPSES;

EID: 68749108090     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9161-7     Document Type: Article

References (61)

1. H Adle-Biassette Y Levy M Colombel F Poron S Natchev C Keohane F Gray 1995 Neuronal apoptosis in HIV infection in adults Neuropathol Appl Neurobiol 21 218 227 10.1111/j.1365-2990.1995.tb01053.x
2. ER Anderson J Boyle WE Zink Y Persidsky HE Gendelman H Xiong 2003 Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis Neuroscience 118 359 369 10.1016/S0306-4522(02)00925-9 (Pubitemid 36423251)
3. ER Anderson HE Gendelman H Xiong 2004 Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis J Neurosci 24 7194 7198 10.1523/JNEUROSCI.1933-04.2004 (Pubitemid 39096385)
4. A Antinori G Arendt JT Becker BJ Brew DA Byrd M Cherner DB Clifford P Cinque LG Epstein K Goodkin M Gisslen I Grant RK Heaton J Joseph K Marder CM Marra JC McArthur M Nunn RW Price L Pulliam KR Robertson N Sacktor V Valcour VE Wojna 2007 Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 1789 1799 10.1212/01.WNL.0000287431.88658.8b (Pubitemid 350059308)
5. N Avgeropoulos B Kelley L Middaugh S Arrigo Y Persidsky HE Gendelman WR Tyor 1998 SCID mice with HIV encephalitis develop behavioral abnormalities J Acquir Immune Defic Syndr Hum Retrovirol 18 13 20
6. C Beeton J Barbaria P Giraud J Devaux AM Benoliel M Gola JM Sabatier D Bernard M Crest E Beraud 2001 Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation J Immunol 166 936 944
7. CT Bever Jr 1994 The current status of studies of aminopyridines in patients with multiple sclerosis Ann Neurol 36 Suppl S118 S121 10.1002/ana.410360728 (Pubitemid 24220857)
8. CT Bever Jr D Young PA Anderson A Krumholz K Conway J Leslie N Eddington KI Plaisance HS Panitch S Dhib-Jalbut 1994 The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial Neurology 44 1054 1059
9. R Blunck O Scheel M Muller K Brandenburg U Seitzer U Seydel 2001 New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling J Immunol 166 1009 1015
10. FH Bouwman RL Skolasky D Hes OA Selnes JD Glass TE Nance-Sproson W Royal GJ Dal Pan JC McArthur 1998 Variable progression of HIV-associated dementia Neurology 50 1814 1820
11. FA Davis D Stefoski J Rush 1990 Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis Ann Neurol 27 186 192 10.1002/ana.410270215
12. RJ Ellis R Deutsch RK Heaton TD Marcotte JA McCutchan JA Nelson I Abramson LJ Thal JH Atkinson MR Wallace I Grant 1997 Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group Arch Neurol 54 416 424
13. IP Everall RK Heaton TD Marcotte RJ Ellis JA McCutchan JH Atkinson I Grant M Mallory E Masliah 1999 Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center Brain Pathol 9 209 217
14. L Fox M Alford C Achim M Mallory E Masliah 1997 Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis J Neuropathol Exp Neurol 56 360 368 10.1097/00005072-199704000-00004
15. EK Gallin 1991 Ion channels in leukocytes Physiol Rev 71 775 811
16. HA Gelbard HJ James LR Sharer SW Perry Y Saito AM Kazee BM Blumberg LG Epstein 1995 Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy Neuropathol Appl Neurobiol 21 208 217 10.1111/j.1365-2990.1995.tb01052.x
17. BB Gelman VM Soukup KW Schuenke MJ Keherly C Holzer 3rd FJ Richey CJ Lahart 2004 Acquired neuronal channelopathies in HIV-associated dementia J Neuroimmunol 157 111 119 10.1016/j.jneuroim.2004.08.044 (Pubitemid 39576644)
18. HE Gendelman J Zheng CL Coulter A Ghorpade M Che M Thylin R Rubocki Y Persidsky F Hahn J Reinhard Jr S Swindells 1998 Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia J Infect Dis 178 1000 1007 10.1086/515693
19. C Ghelardini N Galeotti A Bartolini 1998 Influence of potassium channel modulators on cognitive processes in mice Br J Pharmacol 123 1079 1084 10.1038/sj.bjp. 0701709
20. KP Giese JF Storm D Reuter NB Fedorov LR Shao T Leicher O Pongs AJ Silva 1998 Reduced K+ channel inactivation, spike broadening, and after- hyperpolarization in Kvbeta1.1-deficient mice with impaired learning Learn Mem 5 257 273
21. KP Giese M Peters J Vernon 2001 Modulation of excitability as a learning and memory mechanism: a molecular genetic perspective Physiol Behav 73 803 810 10.1016/S0031-9384(01)00517-0 (Pubitemid 32885568)
22. JD Glass SL Wesselingh OA Selnes JC McArthur 1993 Clinical neuropathologic correlation in HIV-associated dementia Neurology 43 2230 2237
23. JD Glass H Fedor SL Wesselingh JC McArthur 1995 Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia Ann Neurol 38 755 762 10.1002/ana.410380510
24. F Gonzalez-Scarano J Martin-Garcia 2005 The neuropathogenesis of AIDS Nat Rev Immunol 5 69 81 10.1038/nri1527 (Pubitemid 40070332)
25. A Haslberger C Romanin R Koerber 1992 Membrane potential modulates release of tumor necrosis factor in lipopolysaccharide-stimulated mouse macrophages Mol Biol Cell 3 451 460
26. Hu D, Liu J, Xiong H (2007) Macrophage activates delayed-rectifier type K+ channels in cultured rat hippocampal neurons. The 37th Annual Meeting of the Society for Neuroscience, Nov 3 to 7, San Diego, California
27. E Irvine J Keblesh J Liu H Xiong 2007 Voltage-gated potassium channel modulation of neurotoxic activity in human immunodeficiency virus type-1(HIV-1)-infected macrophages J Neuroimmune Pharmacol 2 265 269 10.1007/s11481-007-9072-4
28. A Kandanearatchi B Williams IP Everall 2003 Assessing the efficacy of highly active antiretroviral therapy in the brain Brain Pathol 13 104 110
29. M Kaul GA Garden SA Lipton 2001 Pathways to neuronal injury and apoptosis in HIV-associated dementia Nature 410 988 994 10.1038/35073667 (Pubitemid 32335850)
30. TD Langford SL Letendre GJ Larrea E Masliah 2003 Changing patterns in the neuropathogenesis of HIV during the HAART era Brain Pathol 13 195 210
31. JE Lisman KM Harris 1993 Quantal analysis and synaptic anatomy-integrating two views of hippocampal plasticity Trends Neurosci 16 141 147 10.1016/0166-2236(93)90122-3 (Pubitemid 23085470)
32. AB Mackenzie H Chirakkal RA North 2003 Kv1.3 potassium channels in human alveolar macrophages Am J Physiol Lung Cell Mol Physiol 285 L862 L868
33. RC Malenka MF Bear 2004 LTP and LTD: an embarrassment of riches Neuron 44 5 21 10.1016/j.neuron.2004.09.012 (Pubitemid 39348827)
34. N Maruyama Y Kakuta K Yamauchi Y Ohkawara T Aizawa T Ohrui M Nara T Oshiro I Ohno G Tamura 1994 Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages Am J Respir Cell Mol Biol 10 514 520
35. E Masliah N Ge C Achim L Hansen C Wiley 1992 Selective neuronal vulnerability in HIV encephalitis J Neuropathol Exp Neurol 51 585 593 10.1097/00005072-199211000-00003
36. E Masliah RK Heaton TD Marcotte RJ Ellis CA Wiley M Mallory CL Achim JA McCutchan JA Nelson JH Atkinson I Grant 1997 Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center Ann Neurol 42 963 972 10.1002/ana.410420618 (Pubitemid 28008427)
37. JC McArthur N Haughey S Gartner K Conant C Pardo A Nath N Sacktor 2003 Human immunodeficiency virus-associated dementia: an evolving disease J Neurovirol 9 205 221 10.1080/713831484
38. JC McArthur BJ Brew A Nath 2005 Neurological complications of HIV infection Lancet Neurol 4 543 555 10.1016/S1474-4422(05)70165-4 (Pubitemid 41139976)
39. JA McCutchan JW Wu K Robertson SL Koletar RJ Ellis S Cohn M Taylor S Woods R Heaton J Currier PL Williams 2007 HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients AIDS 21 1109 1117 10.1097/QAD.0b013e3280ef6acd (Pubitemid 46763281)
40. C Messier C Mourre B Bontempi J Sif M Lazdunski C Destrade 1991 Effect of apamin, a toxin that inhibits Ca(2+)-dependent K+ channels, on learning and memory processes Brain Res 551 322 326 10.1016/0006-8993(91)90950-Z
41. A Nath 1999 Pathobiology of human immunodeficiency virus dementia Semin Neurol 19 113 127 10.1055/s-2008-1040830
42. JK Neuenburg HR Brodt BG Herndier M Bickel P Bacchetti RW Price RM Grant W Schlote 2002 HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy J Acquir Immune Defic Syndr 31 171 177
43. TD Parsons AJ Braaten CD Hall KR Robertson 2006 Better quality of life with neuropsychological improvement on HAART Health Qual Life Outcomes 4 11 10.1186/1477-7525-4-11 (Pubitemid 43362193)
44. Y Persidsky HE Gendelman 1997 Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia J Leukoc Biol 62 100 106
45. Y Persidsky J Limoges R McComb P Bock T Baldwin W Tyor A Patil H Nottet L Epstein H Gelbard E Flanagan J Reinhard S Pirruccello H Gendelman 1996 Human immunodeficiency virus encephalitis in SCID mice Am J Pathol 149 1027 1053 (Pubitemid 26334186)
46. CK Petito B Roberts 1995 Evidence of apoptotic cell death in HIV encephalitis Am J Pathol 146 1121 1130
47. MR Qiu TJ Campbell SN Breit 2002 A potassium ion channel is involved in cytokine production by activated human macrophages Clin Exp Immunol 130 67 74 10.1046/j.1365-2249.2002.01965.x
48. Reike F, de Warland R, Ruyter van Steveninck R, Bialek W (1997) Spikes: exploring the neural code. MIT, Cambridge, MA
49. CV Remillard JX Yuan 2004 Activation of K+ channels: an essential pathway in programmed cell death Am J Physiol Lung Cell Mol Physiol 286 L49 L67 10.1152/ajplung.00041.2003
50. H Rus CA Pardo L Hu E Darrah C Cudrici T Niculescu F Niculescu KM Mullen R Allie L Guo H Wulff C Beeton SI Judge DA Kerr HG Knaus KG Chandy PA Calabresi 2005 The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain Proc Natl Acad Sci U S A 102 11094 11099 10.1073/pnas.0501770102 (Pubitemid 41105998)
51. N Sacktor RH Lyles R Skolasky C Kleeberger OA Selnes EN Miller JT Becker B Cohen JC McArthur 2001 HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998 Neurology 56 257 260
52. N Sacktor MP McDermott K Marder G Schifitto OA Selnes JC McArthur Y Stern S Albert D Palumbo K Kieburtz JA De Marcaida B Cohen L Epstein 2002 HIV-associated cognitive impairment before and after the advent of combination therapy J Neurovirol 8 136 142 10.1080/13550280290101094 (Pubitemid 36097787)
53. N Sacktor N Nakasujja R Skolasky K Robertson M Wong S Musisi A Ronald E Katabira 2006 Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa Neurology 67 311 314 10.1212/01.wnl. 0000225183.74521.72 (Pubitemid 44305421)
54. AR Sas HA Bimonte-Nelson WR Tyor 2007 Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of interferon-alpha in the brain AIDS 21 2151 2159 10.1097/QAD.0b013e3282f08c2f (Pubitemid 350287212)
55. EI Solntseva V Bukanova Iu VG Skrebitskii 2003 [Memory and potassium channels] Usp Fiziol Nauk 34 16 25
56. D Stefoski FA Davis M Faut CL Schauf 1987 4-Aminopyridine improves clinical signs in multiple sclerosis Ann Neurol 21 71 77 10.1002/ana.410210113 (Pubitemid 17004147)
57. V Tozzi P Balestra S Galgani P Narciso F Ferri G Sebastiani C D'Amato C Affricano F Pigorini FM Pau A De Felici A Benedetto 1999 Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment AIDS 13 1889 1897 10.1097/00002030-199910010-00011 (Pubitemid 29509548)
58. R Vicente A Escalada M Coma G Fuster E Sanchez-Tillo C Lopez-Iglesias C Soler C Solsona A Celada A Felipe 2003 Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages J Biol Chem 278 46307 46320 10.1074/jbc.M304388200 (Pubitemid 37452201)
59. CA Wiley C Achim 1994 Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Ann Neurol 36 673 676 10.1002/ana.410360422 published erratum appears in Ann Neurol 1995 Jan;37(1):140 (Pubitemid 24309385)
60. H Xiong J Zheng M Thylin HE Gendelman 1999 Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products AIDS Res Hum Retroviruses 15 57 63 10.1089/088922299311718 (Pubitemid 29038325)
61. SS Zakharenko SL Patterson I Dragatsis SO Zeitlin SA Siegelbaum ER Kandel A Morozov 2003 Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses Neuron 39 975 990 10.1016/S0896-6273(03)00543-9 (Pubitemid 37130213)